Ambalal Sarabhai Enterprises

What Ambalal Sarabhai Enterprises does

Ambalal Sarabhai Enterprises Limited (ASE) is a publicly listed Indian pharmaceutical and healthcare conglomerate headquartered in Ahmedabad, Gujarat, with operations tracing to the early 1940s when Ambalal Sarabhai initiated pharmaceutical activity in Vadodara. Formally merged into a single entity by Gautam Sarabhai in 1970 and listed on the Bombay Stock Exchange in 1982 (CIN L52100GJ1978PLC003159), ASE operates through nine wholly-owned subsidiaries spanning three business segments: pharmaceuticals (Asence Pharma, Synbiotics, Vovantis Laboratories, Sarabhai Chemicals, Suvik Hitek, Sarabhai M Chemicals), molecular diagnostics (CoSara Diagnostics), and electronics and scientific instruments (Systronics and its Telerad division). Subsidiary Sarabhai M Chemicals operates a coated Vitamin C API plant at Ranoli, Vadodara, and Asence, Inc. is headquartered in New York to support international pharmaceutical exports.

ASE's core technology platforms include synthetic chemistry for niche APIs and intermediates, niche bulk fermentation technology for amphotericin B production (Synbiotics is India's only manufacturer), effervescent tablet and pouch manufacturing with proprietary taste masking (Vovantis), patented PCR-based molecular diagnostics (CoSara), precision analytical instrumentation including Atomic Absorption and UV-VIS Double Beam Spectrophotometers (Systronics), and professional audio/visual broadcasting equipment distributed under a 45+ year Sony partnership (Telerad). Manufacturing facilities hold USFDA, EU GMP, WHO GMP, and PMDA Japan certifications, with routine multi-jurisdictional regulatory inspections. CoSara became one of the first Indian companies licensed for COVID-19 molecular PCR tests and subsequently scaled to 14 IVD-licensed products.

ASE generates revenue through one-time sales of pharmaceutical products (APIs, formulations, veterinary), molecular diagnostic kits, scientific instruments, and broadcasting equipment, primarily via B2B channels. Domestic pharmaceutical distribution is direct (Sarabhai Chemicals oncology/infertility field sales, CoSara diagnostic kits to labs), while instruments and AV equipment move through dealer/OEM networks and Asence Pharma serves as an export house for international markets. Customer segments span healthcare providers, diagnostic laboratories, industrial users in agriculture/pharmaceuticals/power/metallurgy, and broadcasting/education/defence/research institutions. Pricing is not publicly disclosed; the Sarabhai family maintains controlling influence through Chairman Kartikeya Sarabhai (since 1995) and Managing Director Mohal Sarabhai.

Name

Ambalal Sarabhai Enterprises

Legal name

Ambalal Sarabhai Enterprises Limited

Website

https://ase.life

Company type

Public

Founded year

1970

Operating status

Operating

Headcount range

101–250 employees

Short description

Ambalal Sarabhai Enterprises is a publicly listed Indian pharmaceutical and healthcare conglomerate with nine subsidiaries spanning niche API manufacturing, fermentation-based antifungals, molecular diagnostics, scientific instruments, and professional audio/visual equipment for domestic and export markets.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Medicinal and Botanical Manufacturing (325411), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

Keywords

• Pharmaceutical manufacturing
• Active pharmaceutical ingredients
• Molecular diagnostics
• Scientific instruments
• Fermentation technology

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Manufacturing: ASE group companies manufacture and market pharmaceutical products including APIs, formulations, specialty chemicals, and veterinary products. Revenue is generated through domestic sales in India and exports through Asence Pharma's export house operations.
2. Molecular Diagnostics Products: CoSara Diagnostics generates revenue from sale of PCR test kits for hepatitis, tuberculosis, COVID-19, dengue, and chikungunya diagnosis and monitoring.
3. Scientific Instruments: Systronics manufactures and sells analytical and test measuring instruments including spectrophotometers, flame photometers for agriculture, pharmaceuticals, power, and metallurgy industries.
4. Broadcasting Equipment: Telerad provides professional and broadcast audio/visual products and solutions, representing international principals and distributing equipment.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels4 records

Core offering

Ambalal Sarabhai Enterprises (ASE) is a publicly listed Indian pharmaceutical and healthcare holding company that manufactures and markets active pharmaceutical ingredients (APIs), pharmaceutical formulations, fermentation-based niche drugs, effervescent products, molecular diagnostic PCR test kits, scientific analytical instruments, and broadcast audio/visual equipment through nine wholly-owned subsidiaries. Group companies include Asence Pharma (APIs and formulations export), Synbiotics (amphotericin B), Vovantis (effervescents), CoSara Diagnostics (PCR kits), Sarabhai Chemicals (oncology/infertility), Suvik Hitek (branded and veterinary generics), Sarabhai M Chemicals (Vitamin C), Systronics (analytical instruments) and Telerad (broadcast AV).

Product overview

Ambalal Sarabhai Enterprises (ASE) is a diversified conglomerate with a portfolio of nine subsidiary companies across three main business segments: Pharmaceuticals (Asence Pharma, Synbiotics, Vovantis Laboratories, Sarabhai Chemicals, Suvik Hitek, Sarabhai M Chemicals), Molecular Diagnostics (CoSara Diagnostics), and Electronics/Scientific Instruments (Systronics, Telerad). The company operates as a platform of distinct entities contributing unique expertise, with emphasis on technology-driven manufacturing across niche APIs, fermentation products, effervescent formulations, diagnostic test kits, analytical instruments, and broadcasting equipment. The subsidiaries include: Asence Pharma (APIs and formulations export), Synbiotics (amphotericin B fermentation), Vovantis (effervescent products), CoSara (molecular diagnostics/PCR kits), Sarabhai Chemicals (oncology/profertility), Suvik Hitek (generic/veterinary pharma), Systronics (scientific instruments), Telerad (broadcast equipment), and Sarabhai M Chemicals (Vitamin C).

Differentiator

Problem solved

Functional benefit

Brands

• Asence: Pharmaceutical manufacturing company with capabilities in APIs and formulations, subsidiary of Asence Inc., New York
• Synbiotics
• Vovantis
• CoSara
• Sarabhai Chemicals
• Suvik
• Systronics
• Telerad
• Sarabhai M Chemicals

Products and services

• Asence Pharma Pvt Ltd - APIs and Formulations Export Asence Pharma is a subsidiary of Asence, Inc., New York, USA, operating as an export house with a wide range of internationally approved pharmaceutical manufacturing capabilities in APIs and formulations for global markets.
• Synbiotics - Amphotericin B (Niche Fermentation API) Synbiotics manufactures oral/topical, parenteral, and lyophilized bulk amphotericin B, a broad spectrum antifungal and the only drug for treatment of mucormycosis (black fungus), using niche fermentation technology. India is only manufacturer.
• Vovantis Laboratories - Effervescent Products Manufacturing Vovantis Laboratories has an international standard custom manufacturing facility in India focusing on effervescent products with superior taste masking techniques, complying with USFDA and WHO GMP standards.
• CoSara Diagnostics - PCR Molecular Diagnostic Test Kits CoSara produces patented, high quality and cost effective PCR-based molecular diagnostic test kits for the diagnosis and monitoring of hepatitis, tuberculosis, COVID-19, dengue, and chikungunya, manufactured in a GMP facility.
• Sarabhai Chemicals - Oncology and Infertility Products Sarabhai Chemicals promotes a range of Sarabhai brand oncology and profertility products directly in India through field sales teams.
• Suvik Hitek - Branded, Generic and Veterinary Pharmaceuticals Suvik Hitek manufactures and promotes branded and generic pharmaceutical products, and veterinary therapeutic and prophylactic products, for the Indian market.
• Systronics - Analytical and Test Measuring Instruments Systronics develops, manufactures, and promotes high-quality analytical and test and measuring instruments, including Atomic Absorption Spectrophotometer Model 271, Flame Photometer Model 1027, and UV-VIS Double Beam Spectrophotometer Model 2206-TS, for industries including agriculture, pharmaceuticals, power, and metallurgy.
• Telerad - Broadcast and Professional Audio/Visual Equipment Telerad (a division of Systronics) provides high-quality broadcast and professional audio/visual products and solutions for broadcast, education, defence, research, and houses of worship sectors, distributing Sony equipment in India.
• Sarabhai M Chemicals - Coated Vitamin C Bulk API Sarabhai M Chemicals manufactures coated ascorbic acid (Vitamin C) bulk API at a global standard Vitamin C coating plant at Ranoli, Vadodara, with future plans for Vitamin C derivatives and salts.

Quantifiable outcome

• Synbiotics is India's only manufacturer of amphotericin B, critical for treating mucormycosis
• +2 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Six partnerships are on record, tiered core and historical.

• Codiagnostics USAcoreStrategic or Co-development PartnerCoSara Diagnostics is a joint venture between ASE and Codiagnostics USA, producing molecular diagnostic products including PCR test kits. CoSara was one of the first Indian companies to receive license for COVID-19 diagnostic testing.
• Sony Corporation, JapancoreTechnology or IntegrationSystronics entered a partnership with Sony over 45 years ago which continues today, dynamically meeting the new waves of requirements for audio/visual equipment. This enduring partnership enables Systronics to provide professional and broadcast equipment solutions.
• Asence, Inc., New York, USAcoreOEM/ Whitelabel/ Licensing PartnerAsence Pharma Pvt Ltd is a subsidiary of Asence, Inc., New York, USA. The subsidiary operates as an export house with pharmaceutical manufacturing capabilities in APIs and formulations, serving international markets.
• E.R. Squibb & Sons, USA (Historical)historicalStrategic or Co-development PartnerDr. Vikram Sarabhai established technical collaboration with E.R. Squibb & Sons in 1950, which led to formation of Synbiotics in 1960 for bulk antibiotics using fermentation technology. This collaboration ended but established ASE's pharmaceutical capabilities.
• E. Merck, Germany (Historical)historicalTechnology or IntegrationIn 1958, ASE established collaboration with E. Merck for manufacture of Vitamin C and Fine Chemicals, contributing to the foundation of Sarabhai M Chemicals.
• J.R. Geigy, Switzerland (Historical)historicalTechnology or IntegrationIn 1955, collaboration established with J.R. Geigy for manufacture of pharmaceuticals, textiles, auxiliaries, and dyes.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Suven Life Sciences: Mid-cap Indian pharma with API manufacturing, CDMO services and CNS-focused formulations. Comparable to ASE as a smaller-scale Indian API/formulation manufacturer with regulatory approvals and export exposure.
• SeQuent Scientific: Indian pharmaceutical company focused on veterinary APIs/formulations and human APIs. Comparable to ASE's Suvik Hitek veterinary franchise and broader API manufacturing model.
• Granules India: Indian API and finished dosage manufacturer with USFDA-approved facilities and a strong export franchise. Comparable to ASE in API-led manufacturing with global regulatory compliance and B2B pharma distribution.
• Ipca Laboratories: Indian pharma company manufacturing APIs and formulations across therapeutic areas with strong export presence. Comparable to ASE in regulated API/formulation manufacturing and Indian-domestic plus international sales mix.
• Syngene International: Indian CRO/CDMO providing API development, manufacturing services and research support to global pharma. Comparable to ASE's Asence Pharma and Synbiotics as a regulated pharma services and API manufacturer with international customers.
• Cadila Healthcare (Zydus): Diversified Indian pharmaceutical conglomerate spanning APIs, formulations, biosimilars and consumer health, with USFDA-approved manufacturing and global export operations. Closest structural comparable to ASE's multi-subsidiary pharma platform.
• Aurobindo Pharma: Indian pharma company with large-scale API and generic formulation manufacturing, strong USFDA- and EU-approved facilities, and a dominant global export franchise. Comparable to ASE's API manufacturing and export-house model via Asence Pharma.

Broad incumbents

• Lupin: Indian pharma major with global API and finished dosage manufacturing, USFDA-approved plants, and specialty therapy focus. Comparable to ASE's regulated API/formulation manufacturing and US export orientation.
• Dr. Reddy's Laboratories: Diversified Indian pharma company with API manufacturing, branded generics, biosimilars and global subsidiaries. Comparable to ASE in the breadth of regulated manufacturing and global export ambitions.
• Cipla: One of India's largest pharmaceutical majors with diversified API/formulation manufacturing, respiratory and biosimilar franchises, and global regulatory reach. Comparable to ASE as a broad Indian pharma exporter with multiple niche therapy areas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles23 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ambalal Sarabhai Enterprises